Literature DB >> 10779155

Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats.

V N Anisimov1, I G Popovich, A V Shtylik, M A Zabezhinski, H Ben-Huh, P Gurevich, V Berman, Y Tendler, I Zusman.   

Abstract

Forty-eight two-month-old outbred female LIO rats were injected weekly with a single dose of 1,2-dimethylhydrazine (DMH; 21 mg/kg of body weight) administered s.c. for 15 consecutive weeks. From the day of the 1st injection of the carcinogen the part of rats were given five days a week during the night time (from 18.00 h to 08.00 h) melatonin dissolved in tap water, 20 mg/l. 10 rats were treated similarly with solvents and served as control. The experiment was terminated 6 months after the first injection of the carcinogen. Colon tumors (mainly adenocarcinomas) developed in a hundred percent of rats exposed both to DMH or to DMH plus melatonin. However, descending colon carcinomas were observed in 65 % of rats exposed to DMH plus melatonin against 100% in those exposed to DMH alone (p < 0.01). The multiplicity of colon tumors was also reduced in rats under the influence of melatonin. This effect is correlated with the significant inhibitory effect of the pineal hormone on mitotic index and with stimulating effect of melatonin on the relative number of apoptotic cells (TUNEL-method) in colon tumors. Long-term treatment with melatonin was followed also by the decrease in the area of lymphoid infiltrates in the colon mucosa of tumor-bearing rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779155     DOI: 10.1016/S0940-2993(00)80022-6

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  8 in total

1.  Microarray technology in studying the effect of melatonin on gene expression in the mouse heart.

Authors:  S V Anisimov; K R Boheler; V N Anisimov; K P Boheler
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

2.  Effect of melatonin on the induction of foci of aberrant crypts in the colon by azoxymethane in rats.

Authors:  John H Weisburger; Abraham Rivenson; Chang-In Choi; Joel Reinhardt; Brian Pittman; Edith Zang
Journal:  Environ Health Prev Med       Date:  2004-09       Impact factor: 3.674

Review 3.  Melatonin: Pharmacology, Functions and Therapeutic Benefits.

Authors:  Sylvie Tordjman; Sylvie Chokron; Richard Delorme; Annaëlle Charrier; Eric Bellissant; Nemat Jaafari; Claire Fougerou
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

4.  Rotating night shift work and colorectal cancer risk in the nurses' health studies.

Authors:  Kyriaki Papantoniou; Elizabeth E Devore; Jennifer Massa; Susanne Strohmaier; Céline Vetter; Lin Yang; Yan Shi; Edward Giovannucci; Frank Speizer; Eva S Schernhammer
Journal:  Int J Cancer       Date:  2018-09-24       Impact factor: 7.396

Review 5.  Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action.

Authors:  Hucong Wu; Jiaqi Liu; Yi Yin; Dong Zhang; Pengpeng Xia; Guoqiang Zhu
Journal:  Biomed Res Int       Date:  2019-09-17       Impact factor: 3.411

Review 6.  The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.

Authors:  Anna Hagström; Ruba Kal Omar; Pete A Williams; Gustav Stålhammar
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

Review 7.  Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?

Authors:  E S Schernhammer; K Schulmeister
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

Review 8.  The role of melatonin in colorectal cancer treatment: a comprehensive review.

Authors:  Mindaugas Kvietkauskas; Viktorija Zitkute; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Ther Adv Med Oncol       Date:  2020-07-17       Impact factor: 8.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.